Financial Disclosure

London – September 20, 2026 -- Confidence in alternative data budgets has reached its highest level in three years, with 97% of data buyers expecting spend to increase or hold steady over the next 12 months, according to Neudata's new report, The Future of Alternative and Market Data 2026.

Budget optimism climbs to a record high among data buyers

The figure is up from 89% last year, marking the strongest confidence Neudata has recorded since launching the survey three years ago. The report draws on 191 responses from data providers and buyers globally, the firm's largest sample to date, spanning quant, multi-strategy, discretionary and macro funds as well as AI research labs. Sixty percent of buyer respondents manage over $1 billion in assets.

LONDON – September 20, 2026 -- ECARX, the Nasdaq-listed automotive intelligence company, has surpassed 12 million vehicle deployments worldwide, spanning 18 OEMs, 28 brands and 159 markets.

ECARX added over 914,000 vehicle deployments in the first half of 2026

The company's in-vehicle technology stack now covers intelligent cockpit systems, vehicle software and OS-level solutions, centralized vehicle computing and ADAS. ECARX supports vehicle programs across brands including Geely, FAW-Hongqi, Lotus, Polestar, Volvo Cars, Renault and Volkswagen, spanning multiple vehicle platforms and technology domains.

ECARX is expanding beyond cockpit systems into integrated computing and software platforms

The broader technology footprint allows ECARX to support a wider range of vehicle functions as automakers shift toward AI-defined vehicle architectures.

Shanghai – September 20, 2026 -- WuXi XDC Cayman Inc. (2268.HK) has out-licensed its proprietary WuXiTecan-2 payload-linker technology platform to Ona Therapeutics under an exclusive global agreement targeting a single antibody-drug conjugate (ADC) candidate.

Deal structure includes upfront payment, milestones and tiered royalties

The agreement grants Ona Therapeutics exclusive global rights to develop an ADC candidate using WuXi XDC's WuXiTecan-2 platform. The total potential deal value comprises an upfront payment plus development, regulatory and sales milestone payments, with WuXi XDC also eligible for tiered royalties on net sales once the resulting product reaches commercialization. WuXi XDC will additionally provide chemistry, manufacturing and controls (CMC) development and manufacturing support through its integrated ADC CRDMO platform.

Shanghai – September 20, 2026 -- 111, Inc. (NASDAQ: YI) reported a net loss of RMB31.7 million (US$4.7 million) for the second quarter of 2026, more than four times the RMB7.3 million loss posted a year earlier, as the Shanghai-based healthcare platform accelerated its shift away from an asset-heavy distribution model.

Net revenue falls 28.3% as company sheds underperforming subsidiaries

Net revenue totaled RMB2.3 billion (US$339.0 million), down from RMB3.2 billion in the prior-year quarter. The company attributed the decline to last year's divestiture of several underperforming subsidiaries, part of a strategy to generate more service-based commission income and reduce operational and capital risk.

London – September 20, 2026 -- ACG Metals Limited (LSE: ACG) has more than quadrupled the post-tax net present value of its Gediktepe mine to approximately $1.2 billion, up from $265 million in 2024, following an updated Competent Person's Report prepared by SRK Consulting.

Ore Reserves jump 43% as copper content rises 34%

Total Ore Reserves increased to 26.5 million tonnes from 18.5 million tonnes in the 2024 CPR. In-situ reserves now contain 176kt of copper, 381kt of zinc, 535koz of gold and 20moz of silver, representing gains of 34%, 1%, 19% and 16% respectively versus the prior estimate.

Average annual output set to climb 60% to 36kt copper equivalent

Between 2027 and 2031, Gediktepe's average annual production is projected to reach approximately 36 kt CuEq, up from an original 20-25 kt target. Over an initial 11-year mine life, the operation is expected to produce a total of 352kt CuEq.

Stockholm – September 20, 2026 -- Swedish Orphan Biovitrum AB (Sobi) has paid Innate Pharma SA USD 75 million as their strategic oncology partnership becomes legally effective, following the expiration of antitrust waiting periods and satisfaction of other closing conditions.

Partnership clears regulatory hurdles first announced September 20, 2026

The deal, initially disclosed on September 20, 2026, grants Sobi exclusive global commercialisation rights to lacutamab pending accelerated approval, with an option to assume full global development rights if Phase 3 results are positive.

Hong Kong – September 20, 2026 -- Marvion Inc. (OTCQB: MVNC) reported first-half 2026 revenue of $1.86 million, up 21% from $1.53 million a year earlier, alongside a 62% increase in gross profit to $1.02 million, according to the Company's Form 10-Q for the six months ended September 20, 2026.

Operating income more than tripled to $286,524 in the first half

Income from operations rose from $85,430 in the first six months of 2025 to $286,524 in the same period of 2026. Net income for the period reached $174,891, compared with $114,778 a year earlier.

Second-quarter gross profit climbs 78% on 18% revenue growth

For the three months ended September 20, 2026, revenue totaled $1.05 million versus $889,768 in the prior-year quarter. Gross profit increased to $544,812 from $305,890, while operating income rose to $166,558 from $23,190. The Company reported quarterly net income of $97,282.

Hellerup, Denmark – September 20, 2026 -- TORM plc has closed a secondary public offering of 9,000,000 Class A common shares sold by OCM Njord Holdings S.à r.l., an entity indirectly owned by funds managed by Oaktree Capital Management, L.P. Following the transaction, the Selling Shareholder retains beneficial ownership of approximately 11.06% of TORM's Class A common shares.

Oaktree-linked seller grants underwriter option for 1,350,000 additional shares

J.P. Morgan Securities LLC acted as sole underwriter for the offering and holds a 30-day option to purchase up to 1,350,000 additional Class A shares. TORM confirmed it did not sell any shares in the transaction and received no proceeds, with the entire offering structured as a divestment by the existing shareholder rather than a capital raise for the company.

New York – September 20, 2026 -- Haymaker Acquisition Corp V priced an initial public offering of 25,000,000 units at $10.00 per unit, raising $250 million for its blank-check vehicle ahead of NYSE trading under ticker "HYACU" starting September 20, 2026.

Units begin trading on NYSE as offering nears close

Each unit comprises one Class A ordinary share and one-third of one redeemable warrant, with each whole warrant exercisable at $11.50 per share. The offering is expected to close on September 20, 2026, subject to customary conditions. An amount equal to $10.00 per unit will be deposited into a trust account upon closing.

Galway, Ireland – September 20, 2026 -- TE Connectivity plc (NYSE: TEL) declared a regular quarterly cash dividend of $0.78 per ordinary share, its board of directors confirmed.

Board Sets December 11 Payment Date

The dividend will be paid on September 20, 2026, to shareholders of record as of the close of business on September 20, 2026.